The IFN-γ-inducible GTPase, irga6, protects mice against toxoplasma gondii but not against plasmodium berghei and some other intracellular pathogens

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Liesenfeld, Oliver ^a,j   Parvanova, Iana ^b,k   Zerrahn, Jens ^c,l   Han, Seong Ji ^a,m   Heinrich, Frederik ^a,n   Muñoz, Melba ^a,o   Kaiser, Frank ^c,p   Aebischer, Toni ^c,q   Buch, Thorsten ^b,r   Waisman, Ari ^b,e,r   Reichmann, Gaby ^d,s   Utermöhlen, Olaf ^b   von Stebut, Esther ^e   von Loewenich, Friederike D ^f   Bogdan, Christian ^f,g,t   Specht, Sabine ^h   Saeftel, Michael ^h,u   Hoerauf, Achim ^h   Mota, Maria M ⁱ   Könen Waisman, Stephanie ^b   Kaufmann, Stefan H E ^c   Howard, Jonathan C ^b   more..

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

^f UNIVERSITY OF FREIBURG   (Germany)

^g UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^h UNIVERSITY OF BONN   (Germany)

ⁱ INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^j Roche Molecular Diagnostics   (United States)

^k Bavarian Research Alliance   (Germany)

^l PAREXEL INTERNATIONAL   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ Deutsches Rheumaforschungszentrum   (Germany)

^o DRFZ Berlin   (Germany)

^p UNIVERSITY COLLEGE LONDON   (United Kingdom)

^q ROBERT KOCH INSTITUTE   (Germany)

^r TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^s PAUL EHRLICH INSTITUT   (Germany)

^t UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^u GLAXOSMITHKLINE   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON GAMMA INDUCIBLE GUANOSINE TRIPHOSPHATASE; IRGA6 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; GUANOSINE TRIPHOSPHATASE; IIGP1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENCEPHALITIS; FIBROBLAST; HUMAN GRANULOCYTIC ANAPLASMOSIS; IN VITRO STUDY; IN VIVO STUDY; INFECTION RESISTANCE; INFECTION SENSITIVITY; LEISHMANIA MAJOR; LEISHMANIA MEXICANA; LEISHMANIASIS; LISTERIA MONOCYTOGENES; LISTERIOSIS; MACROPHAGE; MORTALITY; MOUSE; MOUSE STRAIN; NONHUMAN; PARASITE CLEARANCE; PARASITE CONTROL; PARASITE LOAD; PLASMODIUM BERGHEI; PLASMODIUM BERGHEI INFECTION; PROPHYLAXIS; PROTEIN DEFICIENCY; PROTEIN FAMILY; TOXOPLASMA GONDII; TOXOPLASMOSIS; TUBERCULOSIS; WILD TYPE; ANIMAL; C57BL MOUSE; GROWTH, DEVELOPMENT AND AGING; MACROPHAGE ACTIVATION; PARASITOLOGY; PATHOGENICITY; PHYSIOLOGY; TOXOPLASMA;

ANAPLASMA PHAGOCYTOPHILUM; LEISHMANIA MEXICANA; LISTERIA MONOCYTOGENES; MUS; MYCOBACTERIUM TUBERCULOSIS; PLASMODIUM BERGHEI; TOXOPLASMA GONDII;

ANIMALS; GTP PHOSPHOHYDROLASES; MACROPHAGE ACTIVATION; MICE; MICE, INBRED C57BL; PLASMODIUM BERGHEI; TOXOPLASMA; TOXOPLASMOSIS;

EID: 79959228478     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020568     Document Type: Article

References (56)

1. Montoya JG, Liesenfeld O, (2004) Toxoplasmosis. Lancet 363: 1965-1976.
2. Tenter AM, Heckeroth AR, Weiss LM, (2000) Toxoplasma gondii: from animals to humans. Int J Parasitol 30: 1217-1258.
3. Sinai AP, Joiner KA, (1997) Safe haven: the cell biology of nonfusogenic pathogen vacuoles. Annu Rev Microbiol 51: 415-462.
4. Liu CH, Fan YT, Dias A, Esper L, Corn RA, et al. (2006) Cutting edge: dendritic cells are essential for in vivo IL-12 production and development of resistance against Toxoplasma gondii infection in mice. J Immunol 177: 31-35.
5. Denkers EY, Gazzinelli RT, (1998) Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev 11: 569-588.
6. Suzuki Y, (2002) Host resistance in the brain against Toxoplasma gondii. J Infect Dis 185 (Suppl 1): S58-65.
7. Suzuki Y, Conley FK, Remington JS, (1989) Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice. J Immunol 143: 2045-2050.
8. Suzuki Y, Orellana MA, Schreiber RD, Remington JS, (1988) Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 240: 516-518.
9. Aschner M, (1998) Immune and inflammatory responses in the CNS: modulation by astrocytes. Toxicol Lett 102-103: 283-287.
10. Fagard R, Van Tan H, Creuzet C, Pelloux H, (1999) Differential development of Toxoplasma gondii in neural cells. Parasitol Today 15: 504-507.
11. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD, (1998) How cells respond to interferons. Annu Rev Biochem 67: 227-264.
12. Kang H, Liesenfeld O, Remington JS, Claflin J, Wang X, et al. (2003) TCR V beta 8+ T cells prevent development of toxoplasmic encephalitis in BALB/c mice genetically resistant to the disease. J Immunol 170: 4254-4259.
13. Suzuki Y, (2002) Immunopathogenesis of cerebral toxoplasmosis. J Infect Dis 186 (Suppl 2): S234-240.
14. Martens S, Howard J, (2006) The interferon-inducible GTPases. Annu Rev Cell Dev Biol 22: 559-589.
15. Taylor GA, (2007) IRG proteins: key mediators of interferon-regulated host resistance to intracellular pathogens. Cell Microbiol 9: 1099-1107.
16. Bekpen C, Hunn JP, Rohde C, Parvanova I, Guethlein L, et al. (2005) The interferon-inducible p47 (IRG) GTPases in vertebrates: loss of the cell autonomous resistance mechanism in the human lineage. Genome Biol 6: R92.
17. Carlow DA, Marth J, Clark-Lewis I, Teh HS, (1995) Isolation of a gene encoding a developmentally regulated T cell-specific protein with a guanine nucleotide triphosphate-binding motif. J Immunol 154: 1724-1734.
18. Gilly M, Wall R, (1992) The IRG-47 gene is IFN-gamma induced in B cells and encodes a protein with GTP-binding motifs. J Immunol 148: 3275-3281.
19. Boehm U, Guethlein L, Klamp T, Ozbek K, Schaub A, et al. (1998) Two families of GTPases dominate the complex cellular response to interferon-gamma. J Immunol 161: 6715-6723.
20. Sorace JM, Johnson RJ, Howard DL, Drysdale BE, (1995) Identification of an endotoxin and IFN-inducible cDNA: possible identification of a novel protein family. J Leukoc Biol 58: 477-484.
21. Taylor GA, Jeffers M, Largaespada DA, Jenkins NA, Copeland NG, et al. (1996) Identification of a novel GTPase, the inducibly expressed GTPase, that accumulates in response to interferon gamma. J Biol Chem 271: 20399-20405.
22. Collazo CM, Yap GS, Hieny S, Caspar P, Feng CG, et al. (2002) The function of gamma interferon-inducible GTP-binding protein IGTP in host resistance to Toxoplasma gondii is Stat1 dependent and requires expression in both hematopoietic and nonhematopoietic cellular compartments. Infect Immun 70: 6933-6939.
23. Taylor GA, Collazo CM, Yap GS, Nguyen K, Gregorio TA, et al. (2000) Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP. Proc Natl Acad Sci U S A 97: 751-755.
24. Hunn JP, Feng CG, Sher A, Howard JC, (2011) The Immunity-Related GTPases in mammals- a fast evolving cell-autonomous resistance system against intracellular pathogens. Mammalian Genome 22: 43-54.
25. Hunn JP, Howard JC, (2010) The Mouse Resistance Protein Irgm1 (LRG-47): A regulator or an effector of pathogen defense? PLoS Pathog 6: e1001008.
26. Martens S, Parvanova I, Zerrahn J, Griffiths G, Schell G, et al. (2005) Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases. PLoS Pathog 1: e24.
27. Khaminets A, Hunn JP, Konen-Waisman S, Zhao YO, Preukschat D, et al. (2010) Coordinated loading of IRG resistance GTPases on to the Toxoplasma gondii parasitophorous vacuole. Cell Microbiol 12: 939-961.
28. Mollenkopf HJ, Hahnke K, Kaufmann SH, (2006) Transcriptional responses in mouse lungs induced by vaccination with Mycobacterium bovis BCG and infection with Mycobacterium tuberculosis. Microbes Infect 8: 136-144.
29. Spath GF, Beverley SM, (2001) A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Exp Parasitol 99: 97-103.
30. Von Stebut E, Ehrchen JM, Belkaid Y, Kostka SL, Molle K, et al. (2003) Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice. J Exp Med 198: 191-199.
31. Asanovich KM, Bakken JS, Madigan JE, Aguero-Rosenfeld M, Wormser GP, et al. (1997) Antigenic diversity of granulocytic Ehrlichia isolates from humans in Wisconsin and New York and a horse in California. J Infect Dis 176: 1029-1034.
32. von Loewenich FD, Scorpio DG, Reischl U, Dumler JS, Bogdan C, (2004) Control of Anaplasma phagocytophilum, an obligate intracellular pathogen, in the absence of inducible nitric oxide synthase, phagocyte NADPH oxidase, tumor necrosis factor, Toll-like receptor (TLR)2 and TLR4, or the TLR adaptor molecule MyD88. Eur J Immunol 34: 1789-1797.
33. Parvanova I, Epiphanio S, Fauq A, Golde TE, Prudencio M, et al. (2009) A small molecule inhibitor of signal peptide peptidase inhibits Plasmodium development in the liver and decreases malaria severity. PLoS One 4: e5078.
34. Martens S, Sabel K, Lange R, Uthaiah R, Wolf E, et al. (2004) Mechanisms regulating the positioning of mouse p47 resistance GTPases LRG-47 and IIGP1 on cellular membranes: retargeting to plasma membrane induced by phagocytosis. J Immunol 173: 2594-2606.
35. Tsuji M, Mattei D, Nussenzweig RS, Eichinger D, Zavala F, (1994) Demonstration of heat-shock protein 70 in the sporozoite stage of malaria parasites. Parasitol Res 80: 16-21.
36. Schaible UE, Kaufmann SH, (2002) Studying trafficking of intracellular pathogens in antigen presenting cells. In: Zychlinski A, Sansonnetti P, editors. Methods in Microbiology New York Academic Press pp. 343-360.
37. Martens S, Howard J, (2006) The interferon-inducible GTPases. Annu Rev Cell Dev Biol 22: 559-589.
38. Dunay IR, Heimesaat MM, Bushrab FN, Muller RH, Stocker H, et al. (2004) Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis. Antimicrob Agents Chemother 48: 4848-4854.
39. Boehm U, Guethlein L, Klamp T, Ozbek K, Schaub A, et al. (1998) Two families of GTPases dominate the complex cellular response to IFN-gamma. J Immunol 161: 6715-6723.
40. Zeng J, Parvanova IA, Howard JC, (2009) A dedicated promoter drives constitutive expression of the cell-autonomous immune resistance GTPase, Irga6 (IIGP1) in mouse liver. PLoS ONE 4: e6787.
41. Prudencio M, Rodriguez A, Mota MM, (2006) The silent path to thousands of merozoites: the Plasmodium liver stage. Nat Rev Microbiol. 4 (11): 849-56.
42. Coers J, Bernstein-Hanley I, Grotsky D, Parvanova I, Howard JC, et al. (2008) Chlamydia muridarum evades growth restriction by the IFN-gamma-inducible host resistance factor Irgb10. J Immunol 180: 6237-6245.
43. Nelson DE, Virok DP, Wood H, Roshick C, Johnson RM, et al. (2005) Chlamydial IFN-gamma immune evasion is linked to host infection tropism. Proc Natl Acad Sci U S A 102: 10658-10663.
44. Al-Zeer MA, Al-Younes HM, Braun PR, Zerrahn J, Meyer TF, (2009) IFN-gamma-inducible Irga6 mediates host resistance against Chlamydia trachomatis via autophagy. PLoS ONE 4: e4588.
45. Zhao YO, Khaminets A, Hunn JP, Howard JC, (2009) Disruption of the Toxoplasma gondii parasitophorous vacuole by IFNgamma-inducible immunity-related GTPases (IRG proteins) triggers necrotic cell death. PLoS Pathog 5: e1000288.
46. Zhao Y, Ferguson DJ, Wilson DC, Howard JC, Sibley LD, et al. (2009) Virulent Toxoplasma gondii evade immunity-related GTPase-mediated parasite vacuole disruption within primed macrophages. J Immunol 182 (6): 3775-81.
47. Fentress SJ, Behnke MS, Dunay IR, Mashayekhi M, Rommereim LM, et al. (2010) Phosphorylation of immunity-related GTPases by a Toxoplasma gondii-secreted kinase promotes macrophage survival and virulence.Cell Host Microbe Dec 16;8 (6): 484-95.
48. Steinfeldt T, Könen-Waisman S, Tong L, Pawlowski N, Lamkemeyer T, et al. (2010) Phosphorylation of IRG resistance proteins is an evasion strategy for virulent T. gondii strains. PLoS Biology 8 (12): e1000576 doi:10.1371/journal.pbio.1000576.
49. Collazo CM, Yap GS, Sempowski GD, Lusby KC, Tessarollo L, et al. (2001) Inactivation of LRG-47 and IRG-47 reveals a family of interferon gamma-inducible genes with essential, pathogen-specific roles in resistance to infection. J Exp Med 194: 181-188.
50. Hunn JP, Koenen-Waisman S, Papic N, Schroeder N, Pawlowski N, et al. (2008) Regulatory interactions between IRG resistance GTPases in the cellular response to Toxoplasma gondii. Embo J 27: 2495-2509.
51. Coers J, Starnbach MN, Howard JC, (2009) Modeling infectious disease in mice: co-adaptation and the role of host-specific IFNgamma responses. PLoS Pathog 5: e1000333.
52. Zerrahn J, Schaible UE, Brinkmann V, Guhlich U, Kaufmann SH, (2002) The IFN-inducible Golgi- and endoplasmic reticulum- associated 47-kDa GTPase IIGP is transiently expressed during listeriosis. J Immunol 168: 3428-3436.
53. Hooper M, Hardy K, Handyside A, Hunter S, Monk M, (1987) HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature 326: 292-295.
54. Schenten D, Gerlach VL, Guo C, Velasco-Miguel S, Hladik CL, et al. (2002) DNA polymerase kappa deficiency does not affect somatic hypermutation in mice. Eur J Immunol 32: 3152-3160.
55. Kontgen F, Suss G, Stewart C, Steinmetz M, Bluethmann H, (1993) Targeted disruption of the MHC class II Aa gene in C57BL/6 mice. Int Immunol 5: 957-964.
56. Schwenk F, Baron U, Rajewsky K, (1995) A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res 23: 5080-5081.